SGMT(SGMT)
SGMT
ANALYST COVERAGE7 analysts
BUY
▲ +17.5%upside to target
Key MetricsTTM
Market Cap$221.88M
Revenue TTM$0.00
Net Income TTM-$43.51M
Free Cash Flow-$39.73M
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
Return on Equity-37.6%
Return on Assets-40.4%
Debt / Equity0.00
Current Ratio20.34
EPS TTM$-1.34
PRICE
Prev Close
6.65
Open
6.60
Day Range6.50 – 6.85
6.50
6.85
52W Range3.15 – 11.41
3.15
11.41
44% of range
VOLUME & SIZE
Avg Volume
1.4M
FUNDAMENTALS
P/E Ratio
-5.0x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
47
Bearish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 22
DEx-Dividend
In 90 days
Aug 19
SGMT News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
George Kemble
Country
United States
Website
Eduardo Bruno Martins DPhilChief Medical Officer
Lucas PelkmansCo-Founder
Marie O'FarrellChief Scientific Officer
David A. HappelChief Executive Officer, President & Director
Robert D'UrsoSenior Vice President of New Products
Thierry ChaucheChief Financial Officer & Principal Accounting Officer
Elizabeth RozekChief Legal & Administrative Officer
Andreas GrauerChief Medical Officer
Urs GreberCo-Founder